{"transactions":[{"id":828457,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":56110,"kind":"person","name":"FLAVIN JOHN L","position":1,"cik":"0001126556","reported_name":"FLAVIN JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-25T17:10:59.000Z","date":"2026-03-24","kind":"grant","planned":false,"acquired":true,"shares":45867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":45867,"derivative":{"exercise_price":1.36,"expiration_date":"2036-03-24","underlying":"Common Stock","underlying_shares":45867},"source":{"system":"sec-edgar","filing":"0001193125-26-124348","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126556/000119312526124348/ownership.xml","form_type":"4"}},{"id":1184239,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":56110,"kind":"person","name":"FLAVIN JOHN L","position":1,"cik":"0001126556","reported_name":"FLAVIN JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-02T08:55:19.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":36979,"price":0.98,"value":36239.42,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":36979,"derivative":{"exercise_price":0.98,"expiration_date":"2035-03-31","underlying":"Common Stock","underlying_shares":36979},"source":{"system":"sec-edgar","filing":"0000950170-25-048892","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126556/000095017025048892/ownership.xml","form_type":"4"}},{"id":1558688,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":56110,"kind":"person","name":"FLAVIN JOHN L","position":1,"cik":"0001126556","reported_name":"FLAVIN JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-28T16:33:18.000Z","date":"2024-03-26","kind":"grant","planned":false,"acquired":true,"shares":35219,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":413015,"source":{"system":"sec-edgar","filing":"0000950170-24-038104","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126556/000095017024038104/ownership.xml","form_type":"4"}},{"id":1937096,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":56110,"kind":"person","name":"FLAVIN JOHN L","position":1,"cik":"0001126556","reported_name":"FLAVIN JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-28T16:43:00.000Z","date":"2023-03-24","kind":"grant","planned":false,"acquired":true,"shares":139355,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":377796,"source":{"system":"sec-edgar","filing":"0001209191-23-021407","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126556/000120919123021407/doc4.xml","form_type":"4"}},{"id":2309042,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":56110,"kind":"person","name":"FLAVIN JOHN L","position":1,"cik":"0001126556","reported_name":"FLAVIN JOHN L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-04-04T16:16:05.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":66831,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":238441,"source":{"system":"sec-edgar","filing":"0001140361-22-012921","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126556/000114036122012921/form4.xml","form_type":"4"}},{"id":2541852,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":56110,"kind":"person","name":"FLAVIN JOHN L","position":1,"cik":"0001126556","reported_name":"FLAVIN JOHN L","relationship":{"director":true}}],"security":"Series B Convertible Preferred Stock","published_at":"2021-10-15T17:35:34.000Z","date":"2021-10-13","kind":"exercise","acquired":false,"shares":15190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of Series B Convertible Preferred Stock converted automatically and for no additional consideration into Common Stock on a 6.359-for-1 basis upon completion of the Issuer's initial public offering (with fractional shares paid out in cash). The shares of Series B Convertible Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of Series B Convertible Preferred Stock converted automatically and for no additional consideration into Common Stock on a 6.359-for-1 basis upon completion of the Issuer's initial public offering (with fractional shares paid out in cash). The shares of Series B Convertible Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of Series B Convertible Preferred Stock converted automatically and for no additional consideration into Common Stock on a 6.359-for-1 basis upon completion of the Issuer's initial public offering (with fractional shares paid out in cash). The shares of Series B Convertible Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2388},"source":{"system":"sec-edgar","filing":"0001140361-21-034643","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1126556/000114036121034643/form4.xml","form_type":"4"}},{"id":2541851,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":56110,"kind":"person","name":"FLAVIN JOHN L","position":1,"cik":"0001126556","reported_name":"FLAVIN JOHN L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-10-15T17:35:34.000Z","date":"2021-10-13","kind":"exercise","acquired":true,"shares":2388,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of Series B Convertible Preferred Stock converted automatically and for no additional consideration into Common Stock on a 6.359-for-1 basis upon completion of the Issuer's initial public offering (with fractional shares paid out in cash). The shares of Series B Convertible Preferred Stock had no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 47,593 shares of restricted stock that are subject to vesting in six, substantially-equal quarterly installments beginning October 22, 2021, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":171610,"source":{"system":"sec-edgar","filing":"0001140361-21-034643","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126556/000114036121034643/form4.xml","form_type":"4"}},{"id":2544723,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":56110,"kind":"person","name":"FLAVIN JOHN L","position":1,"cik":"0001126556","reported_name":"FLAVIN JOHN L","relationship":{"director":true}}],"security":"Stock Option (Right to buy)","published_at":"2021-10-12T19:47:56.000Z","date":"2021-10-07","kind":"grant","acquired":true,"shares":42191,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options vest as to 1/3 of the shares covered by the option on each annual general meeting of the Issuer's stockholders following the October 7, 2021 grant date, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":42191,"derivative":{"exercise_price":16,"expiration_date":"2031-10-07","underlying":"Common Stock","underlying_shares":42191},"source":{"system":"sec-edgar","filing":"0001140361-21-034426","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126556/000114036121034426/form4.xml","form_type":"4"}}]}